id: NEW:extended_release_naltrexone_knowledge_to_sud_medication_treatment_rate_oud
name: Knowledge of Extended-Release Naltrexone Treatment Options â†’ Medication Treatment Rate for OUD
from_node:
  node_id: NEW:extended_release_naltrexone_knowledge
  node_name: Knowledge of Extended-Release Naltrexone Treatment Options
to_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: Medication Treatment Rate for OUD
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Healthcare systems and providers have limited dissemination of information about extended-release
  naltrexone (XR-NTX) as a treatment option'
- 'Step 2: Patients have limited knowledge regarding XR-NTX compared to buprenorphine'
- 'Step 3: Limited awareness restricts patient ability to make informed treatment choices'
- 'Step 4: Underutilization of XR-NTX as a medication treatment option for OUD'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: B. Tofighi et al. 2019. "Patient Barriers and Facilitators to Medications for Opioid
    Use Disorder in Primary Care." https://doi.org/10.1080/10826084.2019.1653324
  supporting_citations:
  - Additional citations require full-text access
  doi: 10.1080/10826084.2019.1653324
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Limited patient and system-level knowledge about extended-release naltrexone as a treatment
  option restricts uptake of this medication for OUD treatment
quantitative_effects:
  sample_size: 23
structural_competency:
  equity_implications: This mechanism identifies information dissemination and health education as structural
    factors affecting treatment access. The responsibility lies with healthcare systems to provide comprehensive
    information about all treatment options rather than with patients to seek out information.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.231087'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
